Inovio Pharma buy RudolfL
Start price
28.01.21
/
50%
€9.50
Target price
€14.00
Performance (%)
23.16%
End price
04.02.21
€11.70
Summary
This prediction ended on 04.02.21 with a price of €11.70. The prediction had a final performance of 23.16%. RudolfL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Inovio Pharma | - | - | - | - |
| iShares Core DAX® | 1.280% | 1.027% | 11.234% | 16.273% |
| iShares Nasdaq 100 | -2.457% | -4.650% | 23.181% | 39.418% |
| iShares Nikkei 225® | -2.006% | -2.091% | 6.745% | 6.545% |
| iShares S&P 500 | -0.662% | -1.246% | 22.521% | 40.218% |
According to RudolfL what are the pros and cons of Inovio Pharma for the foreseeable future?
Pros
Cons
Risky Investment
High risks for its business
Comments by RudolfL for this prediction
In the thread Inovio Pharma diskutieren
In the thread Trading Inovio Pharma
Stopped prediction by RudolfL for Inovio Pharma
Inovio Pharma
Start price
Target price
Perf. (%)
€19.00
08.03.20
08.03.20
-
22.03.20
22.03.20
-64.47%
22.03.20
22.03.20
Risky Investment
High risks for its business
